1. Home
  2. BNTC vs PCYO Comparison

BNTC vs PCYO Comparison

Compare BNTC & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • PCYO
  • Stock Information
  • Founded
  • BNTC 1995
  • PCYO 1976
  • Country
  • BNTC United States
  • PCYO United States
  • Employees
  • BNTC N/A
  • PCYO N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • PCYO Water Supply
  • Sector
  • BNTC Health Care
  • PCYO Utilities
  • Exchange
  • BNTC Nasdaq
  • PCYO Nasdaq
  • Market Cap
  • BNTC 255.9M
  • PCYO 271.7M
  • IPO Year
  • BNTC N/A
  • PCYO N/A
  • Fundamental
  • Price
  • BNTC $11.30
  • PCYO $11.49
  • Analyst Decision
  • BNTC Strong Buy
  • PCYO
  • Analyst Count
  • BNTC 7
  • PCYO 0
  • Target Price
  • BNTC $24.43
  • PCYO N/A
  • AVG Volume (30 Days)
  • BNTC 24.1K
  • PCYO 35.5K
  • Earning Date
  • BNTC 02-14-2025
  • PCYO 04-09-2025
  • Dividend Yield
  • BNTC N/A
  • PCYO N/A
  • EPS Growth
  • BNTC N/A
  • PCYO 103.72
  • EPS
  • BNTC N/A
  • PCYO 0.55
  • Revenue
  • BNTC N/A
  • PCYO $29,113,000.00
  • Revenue This Year
  • BNTC N/A
  • PCYO N/A
  • Revenue Next Year
  • BNTC N/A
  • PCYO N/A
  • P/E Ratio
  • BNTC N/A
  • PCYO $20.89
  • Revenue Growth
  • BNTC N/A
  • PCYO 56.25
  • 52 Week Low
  • BNTC $3.66
  • PCYO $8.94
  • 52 Week High
  • BNTC $13.29
  • PCYO $14.63
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 52.38
  • PCYO 43.48
  • Support Level
  • BNTC $10.92
  • PCYO $11.23
  • Resistance Level
  • BNTC $11.65
  • PCYO $12.25
  • Average True Range (ATR)
  • BNTC 0.70
  • PCYO 0.28
  • MACD
  • BNTC 0.06
  • PCYO 0.03
  • Stochastic Oscillator
  • BNTC 61.54
  • PCYO 25.49

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About PCYO Pure Cycle Corporation

Pure Cycle Corp is a diversified land and water resource development company. It designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The company's services include water production, storage, treatment, bulk transmission to retail distribution systems, wastewater collection and treatment, irrigation water treatment and transmission, construction management, billing, and collection. The land resource development segment includes all the activities necessary to develop and sell finished lots.

Share on Social Networks: